-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O3o6NfJqf0HFB8K6ZXdoWcKo6ArUFvgteTUB9YVnvlmQtssLIPdi5CCf8R0mBdJd 86J6UruacjYUYLV2GGuIQw== 9999999997-06-045926.txt : 20061116 9999999997-06-045926.hdr.sgml : 20061116 20061116170450 ACCESSION NUMBER: 9999999997-06-045926 CONFORMED SUBMISSION TYPE: REGDEX PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: FILED AS OF DATE: 20061102 DATE AS OF CHANGE: 20061116 EFFECTIVENESS DATE: 20061102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KADMUS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001163571 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: REGDEX SEC ACT: 1934 Act SEC FILE NUMBER: 021-48380 FILM NUMBER: 06061744 MAIL ADDRESS: STREET 1: 2730 SAND HILL RD STE 200 CITY: MENLO PARK STATE: CA ZIP: 94025 REGDEX 1 9999999997-06-045926.paper AUTO-GENERATED PAPER DOCUMENT This document was generated as part of a paper submission. Please reference the Document Control Number 06061744 for access to the original document. -----END PRIVACY-ENHANCED MESSAGE-----